[
  {
    "ts": "2026-02-09T06:00:00+00:00",
    "headline": "Evinova and Bristol Myers Squibb Forge Strategic Collaboration to Optimize Clinical Development with Artificial Intelligence",
    "summary": "BAAR, Switzerland, February 09, 2026--Evinova and Bristol Myers Squibb Forge Strategic Collaboration to Optimize Clinical Development with Artificial Intelligence",
    "url": "https://finance.yahoo.com/news/evinova-bristol-myers-squibb-forge-060000425.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "2c90927b-445d-31c1-bbf9-e48db3de11c5",
      "content": {
        "id": "2c90927b-445d-31c1-bbf9-e48db3de11c5",
        "contentType": "STORY",
        "title": "Evinova and Bristol Myers Squibb Forge Strategic Collaboration to Optimize Clinical Development with Artificial Intelligence",
        "description": "",
        "summary": "BAAR, Switzerland, February 09, 2026--Evinova and Bristol Myers Squibb Forge Strategic Collaboration to Optimize Clinical Development with Artificial Intelligence",
        "pubDate": "2026-02-09T06:00:00Z",
        "displayTime": "2026-02-09T06:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/4d2e1496798a9683f9ff6f798b89c932",
          "originalWidth": 1858,
          "originalHeight": 417,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/IAU6g1IHPac3antWej87tg--~B/aD00MTc7dz0xODU4O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/business-wire.com/4d2e1496798a9683f9ff6f798b89c932.cf.webp",
              "width": 1858,
              "height": 417,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/dXgICgHdbUgudIAeI5bJpg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/4d2e1496798a9683f9ff6f798b89c932.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/evinova-bristol-myers-squibb-forge-060000425.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/evinova-bristol-myers-squibb-forge-060000425.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-09T13:33:57+00:00",
    "headline": "Guggenheim Raises its Price Target on Bristol-Myers Squibb Company (BMY) to $72 and Reiterates a Buy Rating",
    "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is included among the 10 Most Profitable Undervalued Stocks to Buy On February 6, 2026, Guggenheim raised its price target on Bristol-Myers Squibb Company (NYSE:BMY) to $72 from $62 and reiterated a Buy rating. The firm significantly increased its estimated probability of success for iber/mezi to 90% from 33% and lifted its […]",
    "url": "https://finance.yahoo.com/news/guggenheim-raises-price-target-bristol-133357957.html",
    "source": "Insider Monkey",
    "provider": "yfinance",
    "raw": {
      "id": "4e73a4f8-59f1-3b5b-abed-19dbbbe23e36",
      "content": {
        "id": "4e73a4f8-59f1-3b5b-abed-19dbbbe23e36",
        "contentType": "STORY",
        "title": "Guggenheim Raises its Price Target on Bristol-Myers Squibb Company (BMY) to $72 and Reiterates a Buy Rating",
        "description": "",
        "summary": "Bristol-Myers Squibb Company (NYSE:BMY) is included among the 10 Most Profitable Undervalued Stocks to Buy On February 6, 2026, Guggenheim raised its price target on Bristol-Myers Squibb Company (NYSE:BMY) to $72 from $62 and reiterated a Buy rating. The firm significantly increased its estimated probability of success for iber/mezi to 90% from 33% and lifted its […]",
        "pubDate": "2026-02-09T13:33:57Z",
        "displayTime": "2026-02-09T13:33:57Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036",
          "originalWidth": 1456,
          "originalHeight": 816,
          "caption": "Guggenheim Raises its Price Target on Bristol-Myers Squibb Company (BMY) to $72 and Reiterates a Buy Rating",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w_.mq2hxLlg_y2nUTx72ng--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036.cf.webp",
              "width": 1456,
              "height": 816,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/t6o8Kx8kFVS_oEolQVNGNA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/insidermonkey.com/4da437b7638100421dc4d0ddd5060036.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Insider Monkey",
          "url": "http://www.insidermonkey.com"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/guggenheim-raises-price-target-bristol-133357957.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/guggenheim-raises-price-target-bristol-133357957.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "BMY"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]